Four essential drugs needed for quality care of the dying: a Delphi-study based international expert consensus opinion ,
The pathogenesis of constipation, J Support Oncol, vol.4, issue.5, pp.213-221, 2006. ,
Opioid-Induced Constipation in Advanced Illness: Safety and Efficacy of Methylnaltrexone Bromide, Clin Med Insights Oncol, vol.5, pp.201-212, 2011. ,
Standardized concept for the treatment of gastrointestinal dysmotility in critically ill patients???Current status and future options, Clinical Nutrition, vol.27, issue.1, pp.25-41, 2008. ,
DOI : 10.1016/j.clnu.2007.08.001
Constipation et traitements par les opioïdes Physiopathologie et prise en charge. Douleurs : Evaluation -Diagnostic -Traitement, pp.171-178, 2009. ,
Recommandations pour la pratique clinique dans la prise en charge et le traitement de la constipation chronique de l???adulte, Gastroent??rologie Clinique et Biologique, vol.31, issue.2, pp.125-135, 2007. ,
DOI : 10.1016/S0399-8320(07)89342-0
Abnormalities of nerve fibers in the circular muscle of patients with slow transit constipation, International Journal of Colorectal Disease, vol.13, issue.5-6, pp.5-6208, 1998. ,
DOI : 10.1007/s003840050163
EFFECT OF DIETARY FIBRE ON STOOLS AND TRANSIT-TIMES, AND ITS ROLE IN THE CAUSATION OF DISEASE, The Lancet, vol.300, issue.7792, pp.1408-1420, 1972. ,
DOI : 10.1016/S0140-6736(72)92974-1
Pathophysiology of constipation in the older adult, World Journal of Gastroenterology, vol.14, issue.17, p.2631, 2008. ,
DOI : 10.3748/wjg.14.2631
Cancer constipation: are opioids really the culprit? Support Care Cancer, pp.427-436, 2008. ,
Adrenergic mechanisms in the control of gastrointestinal motility: From basic science to clinical applications, Pharmacology & Therapeutics, vol.69, issue.1, pp.59-78, 1996. ,
DOI : 10.1016/0163-7258(95)02031-4
Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives, Journal of Gastroenterology, vol.70, issue.2, 2013. ,
DOI : 10.1007/s00535-013-0753-x
Pharmacology of peripheral opioid receptors, Current Opinion in Anaesthesiology, vol.24, issue.4, pp.408-421, 2011. ,
DOI : 10.1097/ACO.0b013e32834873e5
The involvement of the ??-opioid receptor in gastrointestinal pathophysiology: Therapeutic opportunities for antagonism at this receptor, Pharmacology & Therapeutics, vol.117, issue.1, pp.162-87, 2008. ,
DOI : 10.1016/j.pharmthera.2007.09.007
Opioid bowel dysfunction in acute and chronic nonmalignant pain, Handbook of opioid bowel syndrome, pp.101-120, 2007. ,
Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden, International Journal of Clinical Practice, vol.10, issue.Suppl. 1, pp.1181-1188, 2007. ,
DOI : 10.1111/j.1742-1241.2007.01415.x
Function of opioids in the enteric nervous system, Neurogastroenterology and Motility, vol.247, issue.s2, pp.17-28, 2004. ,
DOI : 10.1016/0014-2999(87)90409-2
Short reports: Morphine, constipation and performance status in advanced cancer patients, Palliative Medicine, vol.13, issue.2, pp.159-60, 1999. ,
DOI : 10.1191/026921699677653615
Opioid bowel dysfunction in palliative care Handbook of opioid bowel syndrome, 1 st ed, pp.69-100, 2007. ,
Opioid receptor signaling: relevance for gastrointestinal therapy, Current Opinion in Pharmacology, vol.6, issue.6, pp.559-63, 2006. ,
DOI : 10.1016/j.coph.2006.06.007
Opioids in chronic non-cancer pain: systematic review of efficacy and safety, Pain, vol.112, issue.3, pp.372-80, 2004. ,
DOI : 10.1016/j.pain.2004.09.019
Accompagnement et de Soins Palliatifs Recommandations pour la prévention et le traitement de la constipation induite par les opioïdes chez le patient relevant de soins palliatifs, Méd. Palliat, vol.8, pp.5-33, 2009. ,
Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial, Pain, vol.101, issue.1, pp.193-201, 2003. ,
DOI : 10.1016/S0304-3959(02)00328-7
Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group, J Pain Symptom Manage, 1996. ,
Incidence, Prevalence, and Management of Opioid Bowel Dysfunction, The American Journal of Surgery, vol.182, issue.5, pp.11-18, 2001. ,
DOI : 10.1016/S0002-9610(01)00782-6
Validated tools for evaluating opioid-induced bowel dysfunction, Advances in Therapy, vol.12, issue.suppl.2, pp.279-94 ,
DOI : 10.1007/s12325-011-0006-4
Constipation--modern laxative therapy. Support Care Cancer, pp.679-85, 2003. ,
A Review of the Potential Role of Methylnaltrexone in Opioid Bowel Dysfunction, The American Journal of Surgery, vol.182, issue.5, pp.19-26, 2001. ,
DOI : 10.1016/S0002-9610(01)00783-8
Constipation and palliative care ??? where are we now?, International Journal of Palliative Nursing, vol.13, issue.1, 2007. ,
DOI : 10.12968/ijpn.2007.13.1.22776
Cancer-related constipation, Current Oncology Reports, vol.131, issue.16S, pp.278-84, 2007. ,
DOI : 10.1007/s11912-007-0034-z
Attitude of Swiss physicians towards opioid-induced constipation: A national survey, European Journal of Internal Medicine, vol.22, issue.5, pp.527-558, 2011. ,
DOI : 10.1016/j.ejim.2011.02.014
Variation of bowel habit in two population samples., BMJ, vol.2, issue.5470, pp.11-13, 1966. ,
DOI : 10.1136/bmj.2.5470.1095
Constipation: a different entity for patients and doctors. Fam Pract, pp.156-165, 1996. ,
Constipation in Palliative Care: What Do We Use as Definitions and Outcome Measures?, Journal of Pain and Symptom Management, vol.45, issue.4, pp.753-62 ,
DOI : 10.1016/j.jpainsymman.2012.03.016
Validation of a Bowel Function Diary for Assessing Opioid-Induced Constipation, The American Journal of Gastroenterology, vol.105, issue.3, pp.497-506, 2011. ,
DOI : 10.1038/ajg.2010.431
A Guide to Symptom Relief in Palliative Care, 2004. ,
The impact of opioids, anticholinergic medications and disease progression on the prescription of laxatives in hospitalized palliative care patients: a retrospective analysis, Palliative Medicine, vol.24, issue.4, pp.410-418, 2010. ,
DOI : 10.1177/0269216310363649
Self-Reported Constipation in Patients With Advanced Cancer: A Preliminary Report, Journal of Pain and Symptom Management, vol.45, issue.1, pp.23-32, 2013. ,
DOI : 10.1016/j.jpainsymman.2012.01.009
Screening for Constipation in Palliative Care Patients, Journal of Palliative Medicine, vol.12, issue.10, pp.915-935, 2009. ,
DOI : 10.1089/jpm.2009.0054
Level of classification performance of KESS (symptom scoring system for constipation) ,
Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation, Journal of Medical Economics, vol.12, issue.4, pp.371-83, 2009. ,
DOI : 10.3111/13696990903430481
Strategies to Manage the Adverse Effects of Oral Morphine: An Evidence-Based Report, Journal of Clinical Oncology, vol.19, issue.9, pp.2542-54, 2001. ,
DOI : 10.1200/JCO.2001.19.9.2542
T1023 Epidemiology of Opioid Bowel Dysfunction and Narcotic Bowel Syndrome in the Community, Gastroenterology, vol.134, issue.4, 2008. ,
DOI : 10.1016/S0016-5085(08)62184-8
The Prevalence, Severity, and Impact of Opioid-Induced Bowel Dysfunction: Results of a US and European Patient Survey (PROBE 1), Pain Medicine, vol.10, issue.1, pp.35-42, 2009. ,
DOI : 10.1111/j.1526-4637.2008.00495.x
Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain, Neurogastroenterology & Motility, vol.101, issue.4, 2010. ,
DOI : 10.1111/j.1365-2982.2009.01458.x
The relationship between opioid use and laxative use in terminally ill cancer patients, Palliative Medicine, vol.12, issue.5 ,
DOI : 10.1191/026921698674125048
The Health of Nonagenarians, Gerontologia Clinica, vol.11, issue.3, pp.137-181, 1969. ,
DOI : 10.1159/000245227
Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids, Arthritis Research & Therapy, vol.7, issue.5, pp.1046-1051, 2005. ,
DOI : 10.1186/ar1782
Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects, Canadian Medical Association Journal, vol.174, issue.11, pp.1589-94, 2006. ,
DOI : 10.1503/cmaj.051528
Opioids for neuropathic pain, Cochrane Database of Systematic Reviews, vol.293, issue.24, 1996. ,
DOI : 10.1002/14651858.CD006146
The impact of opioids, anticholinergic medications and disease progression on the prescription of laxatives in hospitalized palliative care patients: a retrospective analysis, Palliative Medicine, vol.24, issue.4, pp.410-418, 2010. ,
DOI : 10.1177/0269216310363649
Evaluation of Quality in Patient-Controlled Analgesia Provided by an Acute Pain Service, European Surgical Research, vol.35, issue.4, pp.363-71, 2003. ,
DOI : 10.1159/000070608
A Comparison of Sennosides-Based Bowel Protocols with and without Docusate in Hospitalized Patients with Cancer, Journal of Palliative Medicine, vol.11, issue.4, pp.575-81, 2008. ,
DOI : 10.1089/jpm.2007.0178
Standardized concept for the treatment of gastrointestinal dysmotility in critically ill patients???Current status and future options, Clinical Nutrition, vol.27, issue.1, pp.25-41, 2008. ,
DOI : 10.1016/j.clnu.2007.08.001
Sa1150 Efficacy of Pharmacological Therapies for the Treatment of Opioid-Induced Constipation: Systematic Review and Meta-Analysis, Gastroenterology, vol.144, issue.5, 2013. ,
DOI : 10.1016/S0016-5085(13)60756-8
Novel endomorphin analogues with antagonist activity at the mu-opioid receptor in the gastrointestinal tract, Regulatory Peptides, vol.162, issue.1-3 ,
DOI : 10.1016/j.regpep.2010.01.001
Review article: cardiac adverse effects of gastrointestinal prokinetics, Alimentary Pharmacology and Therapeutics, vol.13, issue.12, pp.1585-1591, 1999. ,
DOI : 10.1016/S0196-9781(96)00333-6
European Public Assessment Report of RELISTOR, last updated, 2013. ,
Bioavailability of oral methylnaltrexone increases with a phosphatidylcholine-based formulation. Drug Dev Ind Pharm, 2013. ,
Methylnaltrexone : investigations in treating opioid bowel dysfunction Handbook of opioid bowel syndrome, 1 st ed, pp.197-221, 2007. ,
Methylnaltrexone bromide: research update of pharmacokinetics following parenteral administration, Expert Opinion on Drug Metabolism & Toxicology, vol.28, issue.7, pp.227-262, 2011. ,
DOI : 10.1124/dmd.110.032169
Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans, Xenobiotica, vol.32, issue.11, 1989. ,
DOI : 10.1016/0028-3908(85)90072-3
Constipation sous morphinique : guère plus efficace qu'un placebo, Rev Prescrire, vol.29, issue.305, pp.172-173, 2009. ,
From magic bullets to designed multiple ligands, Drug Discovery Today, vol.9, issue.15, pp.641-651, 2004. ,
DOI : 10.1016/S1359-6446(04)03163-0
Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness: A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study, Journal of Pain and Symptom Management, vol.35, issue.5, pp.458-68, 2008. ,
DOI : 10.1016/j.jpainsymman.2007.12.005
A phase III double-blind placebo-controlled trial of methylnaltrexone (MNTX) for opioid-induced constipation (OIC) in advanced medical illness (AMI), ASCO Annual Meeting Proceedings, p.8003, 2005. ,
DOI : 10.1200/jco.2005.23.16_suppl.lba8003
Methylnaltrexone for Opioid-Induced Constipation in Advanced Illness, New England Journal of Medicine, vol.358, issue.22, pp.2332-2375, 2008. ,
DOI : 10.1056/NEJMoa0707377
The long-term safety of subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic nonmalignant pain, The Journal of Pain, vol.12, issue.4, pp.70-70, 2011. ,
DOI : 10.1016/j.jpain.2011.02.285
Laxatives or methylnaltrexone for the management of constipation in palliative care patients, Cochrane Database Syst Rev, issue.1, p.3448, 2011. ,
1121 POSTER The effect of methylnaltrexone on global clinical impression of change (GCIC) in the bowel status of cancer patients with opioid-induced constipation, European Journal of Cancer Supplements, vol.5, issue.4, p.148, 2007. ,
DOI : 10.1016/S1359-6349(07)70640-7
943a Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Noncancer Pain, Gastroenterology, vol.142, issue.5, pp.160-160, 2012. ,
DOI : 10.1016/S0016-5085(12)60606-4
The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health, Alimentary Pharmacology & Therapeutics, vol.61, issue.Suppl. 2, 2010. ,
DOI : 10.1111/j.1365-2036.2010.04422.x
Stimulant Laxatives and Opioid-Induced Constipation, Journal of Pain and Symptom Management, vol.43, issue.2, pp.306-319, 2012. ,
DOI : 10.1016/j.jpainsymman.2011.12.002
Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic non-malignant pain, The Journal of Pain, vol.10, issue.4, p.52, 2009. ,
DOI : 10.1016/j.jpain.2009.01.277
Common Drug Review, Methylnaltrexone [serial online Available from: URL: <http://www.cadth.ca/media, 2009. ,
Methylnaltrexone in the Treatment of??Opioid-Induced Constipation in Cancer Patients Receiving Palliative Care: Willingness-to-Pay and Cost-Benefit Analysis, Journal of Pain and Symptom Management, vol.41, issue.1, 2009. ,
DOI : 10.1016/j.jpainsymman.2010.04.012
Opioids and the Gastrointestinal Tract - A Case of Narcotic Bowel Syndrome and Literature Review, Journal of Neurogastroenterology and Motility, vol.19, issue.1, 2013. ,
DOI : 10.5056/jnm.2013.19.1.94
The Narcotic Bowel Syndrome: Clinical Features, Pathophysiology, and Management, Clinical Gastroenterology and Hepatology, vol.5, issue.10, pp.1126-1139, 2007. ,
DOI : 10.1016/j.cgh.2007.06.013
Hyperalgésie postopératoire. Douleurs, Feb, vol.7, issue.1, pp.11-17, 2006. ,
Opioid Bowel Dysfunction and Narcotic Bowel Syndrome: A Population-Based Study, The American Journal of Gastroenterology, vol.47, issue.5, pp.1199-204, 2009. ,
DOI : 10.1016/S0885-3924(99)00085-8
Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain, Neurogastroenterology & Motility, vol.101, issue.4, pp.424-430, 2010. ,
DOI : 10.1111/j.1365-2982.2009.01458.x
Narcotic Bowel Syndrome: Is It More Common Than Before?, Journal of Neurogastroenterology and Motility, vol.19, issue.2, p.273 ,
DOI : 10.5056/jnm.2013.19.2.273
Narcotic Bowel Syndrome Treated with ClonidineResolution of Abdominal Pain and Intestinal Pseudo-Obstruction ,
A case of narcotic bowel syndrome successfully treated with clonidine., Postgraduate Medical Journal, vol.70, issue.820, pp.138-178, 1994. ,
DOI : 10.1136/pgmj.70.820.138
Diagnosis, Characterization, and 3-Month Outcome After Detoxification of 39 Patients With Narcotic Bowel Syndrome, The American Journal of Gastroenterology, vol.9, issue.9, pp.1426-1466, 2012. ,
DOI : 10.1038/ajg.2009.341
Effects of methylnaltrexone in patients with narcotic bowel syndrome: a pilot observational study, Internal Medicine Journal, vol.358, issue.1, pp.907-919, 2012. ,
DOI : 10.1111/j.1445-5994.2012.02726.x
Methylnaltrexone for Treatment of Acute Colonic Pseudo-obstruction, Journal of Clinical Gastroenterology, vol.45, issue.10, pp.883-887, 2011. ,
DOI : 10.1097/MCG.0b013e31821100ab
Safety and Efficacy of Methylnaltrexone in Shortening the Duration of Postoperative Ileus Following Segmental Colectomy: Results of Two Randomized, Placebo-Controlled Phase 3 Trials, Diseases of the Colon & Rectum, vol.54, issue.5, pp.570-578, 2011. ,
DOI : 10.1007/DCR.0b013e3182092bde
Standardized concept for the treatment of gastrointestinal 66 ,
Use of Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Critical Care Patients, Mayo Clinic Proceedings, vol.87, issue.3, pp.255-264, 2012. ,
DOI : 10.1016/j.mayocp.2011.11.014
Resolution of opioid-induced postoperative ileus in a newborn infant after methylnaltrexone, Journal of Pediatric Surgery, vol.46, issue.3, pp.13-15, 2011. ,
DOI : 10.1016/j.jpedsurg.2010.10.015
Reversal of morphine-induced urinary retention after methylnaltrexone, Archives of Disease in Childhood - Fetal and Neonatal Edition, vol.97, issue.2, pp.151-153, 2012. ,
DOI : 10.1136/archdischild-2011-300213
Methylnaltrexone for Opioid-Induced Constipation in a Pediatric Oncology Patient, Journal of Pain and Symptom Management, vol.44, issue.1, pp.1-3 ,
DOI : 10.1016/j.jpainsymman.2012.04.001
Methylnaltrexone for Opioid-Induced Constipation in Pediatric Oncology Patients. Pediatr Blood Cancer, 2013. ,
Methylnaltrexone in Treatment of Opioid-induced Constipation in a Pediatric Patient, The Clinical Journal oF Pain, vol.28, issue.4, pp.338-379 ,
DOI : 10.1097/AJP.0b013e31822ad94c
Efficacité et effets indésirables des produits de santé : données confidentielles ou d'intérêt public ?. Rev Presc. [serial online, 2013. ,
Appendix 6b. Including adverse effects, Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [serial online, 2006. ,
Salix and Progenics announce FDA advisory committee to review Relistor sNDA for opioid induced constipation in patients with chronic pain Progenic's Pharmaceutical News [serial online Available from: URL:< http://files.shareholder.com, pp.321-597, 2013. ,
Fedotozine blocks hypersensitive visceral pain in conscious rats: action at peripheral ??-opioid receptors, European Journal of Pharmacology, vol.324, issue.2-3, pp.2-3211, 1997. ,
DOI : 10.1016/S0014-2999(97)00089-7
Peripherally acting opioid antagonists in the treatment of opiate-related constipation: a systematic review, J Pain Symptom Manage, 2007. ,
A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain, Palliative Medicine, vol.26, issue.1, pp.201250-60 ,
DOI : 10.1177/0269216311418869
Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study???, Pain, vol.83, issue.3, pp.631-636, 1999. ,
DOI : 10.1016/S0304-3959(99)00162-1
Mu-opioid antagonists for opioidinduced bowel dysfunction, Cochrane Database Syst Rev, issue.2, p.6332, 2008. ,
Methylnaltrexone for Reversal of Constipation Due to Chronic Methadone Use, JAMA, vol.283, issue.3, pp.367-72, 2000. ,
DOI : 10.1001/jama.283.3.367
Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness: A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study, Journal of Pain and Symptom Management, vol.35, issue.5, pp.458-68, 2008. ,
DOI : 10.1016/j.jpainsymman.2007.12.005
Characterization of Abdominal Pain During Methylnaltrexone Treatment of Opioid-Induced Constipation in Advanced Illness: A Post Hoc Analysis of Two Clinical Trials, Journal of Pain and Symptom Management, vol.42, issue.5, pp.754-60, 2011. ,
DOI : 10.1016/j.jpainsymman.2011.02.015
S1049 Characteristics of Gastrointestinal Adverse Events in Patients With Opioid-Induced Constipation and Chronic Non-Malignant Pain Treated With Subcutaneous Methylnaltrexone, Gastroenterology, vol.138, issue.5, pp.167-167, 2010. ,
DOI : 10.1016/S0016-5085(10)60765-2
Données fondamentales (anatomie, physiologie) sur la sensibilité et la douleur viscérales. Douleur Analg, p.3, 1998. ,
Basic and clinical aspects of gastrointestinal pain, Pain, vol.141, issue.3, 2009. ,
DOI : 10.1016/j.pain.2008.12.011
Gender, Variation in Opioid Receptor Genes and Sensitivity to Experimental Pain, Molecular Pain, vol.32, issue.1, p.20, 2013. ,
DOI : 10.1093/bioinformatics/bth457
Opioid-induced hyperalgesia: a review of epidemiology, mechanisms and management, Singapore Med J, vol.53, issue.5, pp.357-60, 2012. ,
Opioid-induced latent sensitization in a model of non-inflammatory viscerosomatic hypersensitivity, Brain Research, vol.1358, pp.64-70, 2010. ,
DOI : 10.1016/j.brainres.2010.08.032
Withdrawal syndrome caused by naltrexone in opioid abusers, Human & Experimental Toxicology, vol.32, issue.9, 2013. ,
DOI : 10.1177/0960327112450901
P.1.180: INFLUENCE OF NALOXONE AND METHYLNALTREXONE ON INTERDIGESTIVE GASTROINTESTINAL MOTILITY AND HUNGER SCORES IN MAN, Digestive and Liver Disease, vol.43, issue.5, pp.868-868, 2011. ,
DOI : 10.1016/S1590-8658(11)60408-8
420 Effect of Methylnaltrexone on Esophageal Function in Man, Gastroenterology, vol.142, issue.5, pp.93-93, 2012. ,
DOI : 10.1016/S0016-5085(12)60356-4
Opioid-induced Delay in Gastric Emptying, Anesthesiology, vol.87, issue.4, pp.765-70, 1997. ,
DOI : 10.1097/00000542-199710000-00008
Evaluation of methylnaltrexone for the reduction of postoperative vomiting and nausea incidences, Acta Anaesthesiol Belg, vol.46, pp.3-4127, 1995. ,
Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: Role of receptor transactivation, Microvascular Research, vol.72, issue.1-2, pp.3-11, 2006. ,
DOI : 10.1016/j.mvr.2006.04.004
Methylnaltrexone and Gastrointestinal Perforation, Journal of Pain and Symptom Management, vol.40, issue.1, pp.1-3, 2010. ,
DOI : 10.1016/j.jpainsymman.2010.01.011
S final assessment report on PSUR, Federal institute for drugs and medical devices, 2009. ,
EPAR -Procedural steps taken and scientific information after authorization Available from: URL: <http, Relistor, 2013. ,